Result of General Meeting and Total Voting Rights

Science in Sport PLC

24 July 2024

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE.

24 July 2024

Science in Sport plc

("Science in Sport" or the "Company")

Result of General Meeting and Total Voting Rights

On 4 July 2024, Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announced a conditional Placing and Retail Offer.

The Company is pleased to announce that all Resolutions, as set out in the circular sent to its shareholders dated 8 July 2024 (the "Circular") and proposed at the General Meeting held earlier today, were passed.

Further to this, the Company can now confirm that, pursuant to the terms and conditions of the Placing and the Retail Offer, it will issue 49,999,999 new Ordinary Shares at 17 pence per share, raising gross proceeds of approximately £8.5 million (in aggregate). The New Ordinary Shares will be issued as follows:

·    47,058,823 shares pursuant to the Placing, raising gross proceeds of approximately £8.0 million; and

·    2,941,176 shares pursuant to the Retail Offer, raising gross proceeds of approximately £0.5 million.

The Company has applied to the London Stock Exchange for the 49,999,999 New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that the Admission will occur at 8:00 a.m. on 25 July 2024.

Upon Admission, the Company's Enlarged Issued Share Capital will consist of 232,272,606 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, from Admission the total number of Ordinary Shares and voting rights in the Company will be 232,272,606.

Commenting, Daniel Wright, Executive Chair of Science in Sport, said: "We're very pleased to have been able to complete this equity raise with significant support from our existing shareholder base and new investors. The Board would like to thank investors for their continued support. The additional funds raised will enable us to invest in inventory, capital expenditure to improve operational efficiency and develop 'go-to' market strategies in key regions and customer groups, which will drive controlled margin improvements for the Company. Directors have participated significantly in the raise, highlighting both our commitment to and belief in the Company's prospects and opportunities for growth. We look forward to a productive second half of FY24, and beyond, as we continue to execute our strategy."

Terms used but not defined in this announcement have the same meaning as set out in the Circular.

For further information:

Science in Sport plc	T: [phone]
Daniel Wright, Executive Chairman Daniel Lampard, Chief Operating Officer Christopher Welsh, Chief Financial Officer
Panmure Liberum Limited (Nominated Adviser and Broker)	T: [phone]
Richard Lindley John More Anake Singh

About Science in Sport plc

Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.

The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and eBay, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market.

PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart.

SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA. 

SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and Tottenham Hotspur and CGC Nice football clubs. 

For further information, please visit phd.com and scienceinsport.com

 

END